Holmium Laser for Reversal of Cerebral Artery Vasospasm

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$687,478.00
Award Year:
1997
Program:
SBIR
Phase:
Phase II
Contract:
1 R43 HL54398-01,
Award Id:
29540
Agency Tracking Number:
29540
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
3404 N Orange Blossom Trail, Orlando, FL, 32804
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
Peter Moulton
() -
Business Contact:
() -
Research Institution:
n/a
Abstract
Cerebral artery vasospasm may occur in patients suffering from subarachnoid hemorrhage and can resuneurological damage. The number of patients suffering from cerebral vasospasm is in excess of 20,000often produces permanently crippling effects or death in the 30-40 year old age group that exhibitspresent, there is no FDA approved procedure that is capable of permanently dilating the cerebral artbased treatment developed at Massachusetts General Hospital has been shown to reverse cerebral artercanine model. The goal of this Phase I effort will be to measure vasodilation as a function of laserex-vivo, living dog cerebral arteries in spasm. In Phase II, clinical testing would be started in orfavorable results observed in the canine model apply to humans. The long-term goal of the project woFDA approved laser system with fiber-optic delivery that would prevent the crippling effects of this

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government